{
  "trial_id": "NCT01660711",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Histologic or cytologic diagnosis of adenocarcinoma of the pancreas.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Resectable primary tumor of the head, body or tail of the pancreas defined as a visible mass in the pancreas and:",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "No extrapancreatic disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "A patent superior mesenteric (SMV)- portal vein (PV) confluence (assuming the technical ability to resect and reconstruct this venous confluence if needed)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "A definable tissue plane between the tumor and regional arterial structures including the celiac axis, common hepatic artery, and SMA.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Confirmation of resectability by surgical oncology consultation.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Presentation at a multidisciplinary conference at either University of Chicago or NorthShore University",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No previous therapy for pancreatic cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Short removable metal stents rather than plastic stents are preferred but not required for palliation of initial obstructive jaundice",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Karnofsky performance status 80 or better",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age > 21 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No currently active second malignancy",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who have had previous chemotherapy or radiotherapy for pancreatic adenocarcinoma prior to entering the study.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Pathologic subtypes other than pure adenocarcinoma; acinar cell carcinoma, squamous cell carcinoma, spindle cell carcinoma, neuroendocrine cancer, and mixed types are not eligible.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who are receiving any investigational agents.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with borderline resectable, locally advanced or metastatic disease.",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has a history of CAD and recently noted abdominal mass. She presents with fevers/rigors and bandemia. CT abdomen without contrast showed a large heterogeneous left upper abdominal mass consistent with pancreatic adenocarcinoma at the head of pancreas.",
  "_meta": {
    "topic_id": "15",
    "trial_id": "NCT01660711",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}